Inventor · disambiguated record
Axel Metzger
Also filed as: METZGER AXEL
11 granted patents·7 pending applications·210 citations·filing 1997–2022
90Inventor score
Files withVENENUM BIODESIGN LLC4PALATIN TECHNOLOGIES INC3PHARMACOPEIA DRUG DISCOVERY2PHARMACOPEIA INC2BRISTOL MYERS SQUIBB CO1
Top patents by PatentIndex Score
18 records- 0191US6048732AReceptor and method for citrate determinationUNIV TEXAS·Filed 1997·Granted Apr 11, 2000·118 cites·22 claims
- 0290US7253174B2N-heterocyclic inhibitors of TNF-α expressionPHARMACOPEIA INC·Filed 2006·Granted Aug 7, 2007·15 cites·8 claims
- 0387US8263608B2Melanocortin receptor-specific spiro-piperidine compoundsSHI YI-QUN·Filed 2011·Granted Sep 11, 2012·15 cites·15 claims
- 0487US7479495B2N-heterocyclic inhibitors of TNF-α expressionPHARMACOPEIA INC·Filed 2005·Granted Jan 20, 2009·11 cites·32 claims
- 0586US6906067B2N-heterocyclic inhibitors of TNF-α expressionPHARMACEOPEIA INC·Filed 2001·Granted Jun 14, 2005·35 cites·20 claims
- 0685US8044040B2N-heterocyclic inhibitors of TNF-alpha expressionBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 25, 2011·6 cites·2 claims
- 0782US7951803B28-heteroarylpurine MNK2 inhibitors for treating metabolic disordersPHARMACOPEIA LLC·Filed 2007·Granted May 31, 2011·10 cites·20 claims
- 0874US12459894B2Orally active melanocortin receptor-4 compoundsPALATIN TECHNOLOGIES INC·Filed 2022·Granted Nov 4, 2025·0 cites·7 claims
- 0966US11883420B2Sting agonists for treating bladder cancer and solid tumorsVENENUM BIODESIGN LLC·Filed 2021·Granted Jan 30, 2024·0 cites·4 claims
- 1065US11161864B2Sting agonistsVENENUM BIODESIGN LLC·Filed 2019·Granted Nov 2, 2021·0 cites·18 claims
- 1163US11110106B2Sting agonists for treating bladder cancer and solid tumorsVENENUM BIODESIGN LLC·Filed 2020·Granted Sep 7, 2021·0 cites·20 claims
- 1263US2021198201A1Orally Active Melanocortin Receptor-4 CompoundsPALATIN TECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 1361US2023040236A1Diamine-Linked Melanocortin Receptor-Specific Cyclic Peptides for Ocular IndicationsPALATIN TECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1461US2022048936A1Novel sting agonistsVENENUM BIODESIGN LLC·Filed 2021·Application pending·0 cites
- 1549US2003139435A1N-heterocyclic inhibitors of TNF-alpha expressionFiled 2002·Application pending·0 cites
- 1644US2009005568A1Substituted 2-aminothiazoles for treating neurodegenerative diseasesPHARMACOPEIA DRUG DISCOVERY·Filed 2006·Application pending·0 cites
- 1743US2009023723A1Purinone derivatives for treating neurodegenerative diseasesPHARMACOPEIA DRUG DISCOVERY·Filed 2006·Application pending·0 cites
- 1842US2011230480A18-heteroarylpurine mnk2 inhibitors for treating metabolic disordersCOLE ANDREW G·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Axel Metzger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →